How Dolphins May Help Stem the Human Diabetes Pandemic: The Value of One Health
Stephanie Venn-Watson, DVM, MPH
Today, one in three adults in the U.S. has metabolic syndrome, which includes insulin resistance, elevated triglycerides, and chronic inflammation. Just like humans, bottlenose dolphins (Tursiops truncatus) can develop metabolic syndrome, sometimes called prediabetes. Scientists have discovered saturated fat molecules in the dolphin fish diet that are alleviating metabolic syndrome and may do the same for humans. This lecture will discuss how dolphins and humans may have shared evolutionary origins of insulin resistance, why some fish diets could have more benefits than other fish diets, and how collaboration between experts in human and dolphin health can improve global health.
Instructor: Stephanie Venn-Watson is an award-winning veterinary epidemiologist and entrepreneur. She founded the Translational Medicine and Research Program at the National Marine Mammal Foundation, a San Diego-based program that targets clinical research at the intersection of marine mammal and human health. She is the Co-Founder and Chief Executive Officer of Epitracker, a biopharmaceutical company in San Diego, focused on translating knowledge of marine dolphins’ physiology to improved human healthcare. She received her BS in Animal Physiology and Neuroscience from UC San Diego, a DVM from Tufts University, and an MPH from Emory University.
Coordinator: Steve Clarey
Course Number: OSHR-70084 Credit: 0 units
|Dates||Class Type||Section ID||Fee|
Day and Time:
Tuesday, 10:00 a.m. - 12:00 p.m.